Publications by authors named "W E M Ineke Schouten"

Article Synopsis
  • * A validated ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) method was developed to accurately measure DNDI-6148 levels in various biological samples, following international guidelines on bioanalytical methods.
  • * The study found that collagenase A-based enzymatic homogenization extracted DNDI-6148 2.9 times more effectively from mouse skin compared to traditional methods, with consistent accuracy and recovery rates across different biomatrices
View Article and Find Full Text PDF

Background: Endorectal advancement flap repair is often performed for the treatment of cryptoglandular transsphincteric fistulas. However, this procedure fails in approximately 1 of 4 patients. Based on its supposed healing properties, platelet-rich plasma might enhance the outcome of this procedure.

View Article and Find Full Text PDF

Malaria remains a major health concern, aggravated by emerging resistance of the parasite to existing treatments. The World Health Organization recently endorsed the use of artesunate-pyronaridine to treat uncomplicated malaria. However, there is a lack of clinical pharmacokinetic (PK) data of pyronaridine, particularly in special populations such as children and pregnant women.

View Article and Find Full Text PDF

Snakebite envenoming is a priority Neglected Tropical Disease that causes an estimated 81,000-135,000 fatalities each year. The development of a new generation of safer, affordable, and accessible antivenom therapies is urgently needed. With this goal in mind, rigorous characterisation of the specific toxins in snake venom is key to generating novel therapies for snakebite.

View Article and Find Full Text PDF

Snakebite is considered a concerning issue and a neglected tropical disease. Three-finger toxins (3FTxs) in snake venoms primarily cause neurotoxic effects since they have high affinity for nicotinic acetylcholine receptors (nAChRs). Their small molecular size makes 3FTxs weakly immunogenic and therefore not appropriately targeted by current antivenoms.

View Article and Find Full Text PDF